Red X iconGreen tick iconYellow tick icon

Contact Details

Email
phil.heyward@otago.ac.nz
Position
Lecturer
Department
Department of Physiology
Qualifications
BSc (Hons) PhD
Research summary
Neurophysiology and the sense of smell

Research

The sense of smell: Our ability to sense airborne chemicals is based on patterns of neuronal activity in the brain. We use electrophysiological recording from brain slices maintained in vitro to study how these patterns of activity are processed by individual neurons and circuits in the brain.

Neurological disorders: Bipolar disorder, depression and epilepsy seem like very different problems, but they each result from abnormal levels of brain neuron activity. To understand these diseases better and develop better treatments we need to know more about how the current treatments work. We therefore focus our studies on how current treatments act on neurons to control their activity as individuals, and as members of brain circuits.

Publications

Crellin, S., Sheard, P., Heyward, P., Glue, P., & de Ridder, D. (2024, August). Effect of bipolar disorder medications: Ex vivo and clinical results. Verbal presentation at the BMS Postgraduate Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Crellin, S., Glue, P., Sheard, P., Heyward, P. M., & De Ridder, D. (2024, August-September). EEG biomarkers and dysconnectivity in bipolar disorder. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Crellin, S., Sheard, P., Glue, P., Heyward, P. M., & De Ridder, D. (2024, August-September). Novel therapeutic targets in the treatment of bipolar disorder. Poster session presented at the 18th New Zealand Medical Sciences Congress (MedSci), Queenstown, New Zealand. Conference Contribution - Poster Presentation (not in published proceedings)

Heyward, P. M., & Tups, A. (2023). Pharmaceutical combinations and methods for the treatment of diabetes and associated disorders. (11,738,001). United States. Intellectual Property

Pretz, D., Heyward, P. M., Krebs, J., Gruchot, J., Barter, C., Silcock, P., Downes, N., Rizwan, M. Z., Boucsein, A., Bender, J., Burgess, E. J., Boer, G. A., Perry, N. B., & Tups, A. (2023, August-September). A dahlia flower extract has anti-diabetic properties by improving insulin function in the brain. Verbal presentation at the Queenstown Molecular Biology (QMB) Hypothalamic Neuroscience & Neuroendocrinology Australasia (HNNA) Satellite, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Back to top